Top upgrades and downgrades on 6/24: CLR, MRO, SGEN, FUL and more

Analysts Notebook wrote a column · Jun 24, 2022 20:18

Upgrades

• $American Water Works (AWK.US)$ : Janney Upgrades to Buy from Neutral

• $Becton Dickinson & Co (BDX.US)$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $275

• $Altria (MO.US)$ : Morgan Stanley Upgrades to Equalweight from Underweight - PT $43 (from $47)

• $Middlesex Water (MSEX.US)$ : Janney Upgrades to Buy from Neutral

• $Indonesia Energy (INDO.US)$ : Noble Capital Upgrades to Outperform from Market Perform - PT $15

• $Progressive (PGR.US)$ : KBW Upgrades to Market Perform from Underperform - PT $107

• $Sunoco (SUN.US)$ : Mizuho Securities Upgrades to Buy from Neutral - PT $44 (from $46)

• $Tetra Technologies (TTI.US)$ : Johnson Rice Upgrades to Buy from Hold - PT $7

• $Wolfspeed (WOLF.US)$ : Goldman Sachs Upgrades to Buy from Neutral - PT $108

Downgrades

• $Assurant (AIZ.US)$ : Piper Sandler Downgrades to Neutral from Overweight - PT $185 (from $205)

• $Ameriprise Financial (AMP.US)$ : Goldman Sachs Downgrades to Neutral from Buy - PT $270 (from $325)

• $Baxter International Inc (BAX.US)$ : Wells Fargo Downgrades to Equal Weight from Overweight - PT $71

• $Continental Resources (CLR.US)$ : Citigroup Downgrades to Neutral from Buy - PT $70 (from $74)

• $Coterra Energy (CTRA.US)$ : Citigroup Downgrades to Neutral from Buy - PT $27 (from $40)

• $Denny's (DENN.US)$ : Wedbush Downgrades to Neutral from Outperform - PT $10 (from $19)

• $8x8 (EGHT.US)$ : Evercore ISI Downgrades to In Line from Outperform - PT $6 (from $18)

• $F-star Therapeutics (FSTX.US)$ : SVB Leerink Downgrades to Market Perform from Outperform - PT $7

• $H.B. Fuller (FUL.US)$ : JPMorgan Downgrades to Underweight from Neutral - PT $52 (from $70)

• $Hess Corp (HES.US)$ : Citigroup Downgrades to Neutral from Buy - PT $110 (from $126)

• $Marathon Oil(Delisted) (MRO.US)$ : Citigroup Downgrades to Neutral from Buy - PT $24 (from $31)

Initiated

• $Agilon Health (AGL.US)$ : BTIG initiates at Neutral

• $Amyris (AMRS.US)$ : JPMorgan initiates at Neutral

• $Bausch + Lomb Corp. (BLCO.US)$ : Evercore ISI initiates at Outperform - PT $21

• $biote (BTMD.US)$ : Cowen initiates at Outperform - PT $11

• $Caleres (CAL.US)$ : Seaport Global initiates at Buy - PT $35

• $Cano Health (CANO.US)$ : Raymond James initiates at Outperform - PT $8

• $Core Scientific (CORZ.US)$ : Cowen initiates at Outperform - PT $3.10

• $CytomX (CTMX.US)$ : BMO Capital initiates at Outperform - PT $9

• $Exelixis (EXEL.US)$ : BMO Capital initiates at Outperform - PT $28

• $Genmab (GMAB.US)$ : BMO Capital initiates at Market Perform

• $Inter & Co (INTR.US)$ : Goldman Sachs initiates at Sell

• $Iron Mountain (IRM.US)$ : Barclays initiates at Overweight - PT $58

• $MARA Holdings (MARA.US)$ : Cowen initiates at Market Perform - PT $7

• $Nuvalent (NUVL.US)$ : BMO Capital initiates at Outperform - PT $28

• $SpringBig (SBIG.US)$ : Jefferies initiates at Buy - PT $4.50

• $Seagen (SGEN.US)$ : BMO Capital initiates at Market Perform - PT $169

• $Tetra Technologies (TTI.US)$ : Johnson Rice initiates at Buy - PT $7

• $Y-mAbs Therapeutics (YMAB.US)$ : BMO Capital initiates at Outperform - PT $27

Moomoo Inc. ("moomoo") provides mobile and online technology solutions for securities trading. Moomoo is not an investment adviser or a broker-dealer and it provides neither investment or financial advice nor securities trading services. All contents such as comments and links posted or shared by users of the community are opinions of the respective authors only and do not reflect the opinions, views, or positions of moomoo, its affiliates, or any employees of moomoo or its affiliates. Please consult a qualified investment or tax advisor for your personal financial planning and tax situations.

Disclaimer: Moomoo Technologies Inc. is providing this content for information and educational use only. Read more